ReviewCureus2024

Finerenone's Impact on Major Adverse Cardiovascular Events in Chronic Kidney Disease and Type 2 Diabetes Mellitus: A Systematic Review.

Vignesh Murugan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.